Interventions to improve antibiotic stewardship

Since its inception in 2018, the International Centre for Antimicrobial Resistance Solutions (ICARS) has become a key partner of Low- and Middle- Income Countries (LMICs) facilitating their efforts to mitigate antimicrobial resistance (AMR) and implement their AMR National Action Plans by working at both political and technical levels. ICARS kick-started the development of over 30 projects across the One Health spectrum, spanning 16 countries and four continents and has proven itself as an agile and effective[SE1] organisation with a novel value proposition based on intervention and implementation research. To maximize its impact, ICARS has set an ambitious future agenda with its 2022-2026 strategy. The strategic partnership with Wellcome will enable ICARS to expand beyond its current capacity, mature as an organisation and respond to the growing demand from LMICs. Specifically, the partnership will 1) strengthen ICARS’ innovative top-down, bottom-up model and ways of working, 2) facilitate sustainable regional impact by piloting ICARS’ regional presence and 3) harness partnerships for sustainable global impact. The ICARS-Wellcome partnership spanning five years will give effect to the common vision of ICARS and Wellcome of a world where drug-resistant infections no longer pose a threat to the health and wellbeing of humans, animals and the environment.